Trusted News Discovery Since 2008
{{/content}}
US To Resume Johnson & Johnson COVID-19 Vaccinations Despite Rare Blood Clot Risk
Video Credit: CBS 11 Dallas
Published on April 24, 2021 - Duration: 02:12s
US To Resume Johnson & Johnson COVID-19 Vaccinations Despite Rare Blood Clot Risk
The FDA and CDC officially lifted the pause that was put in place last Tuesday, August 13, despite concerns over a potential link to rare and deadly blood clots.
You are here
Related videos from verified sources
Massachusetts COVID-19 vaccine appointments becoming easier to find 01:39
Video credit: WCVB - Published on April 29, 2021
Reporter Update: More Clotting Cases Reported With J&J Vaccine 00:23
Video credit: KDKA CBS 2 Pittsburgh - Published on April 28, 2021
What's concerning about rare cases of Johnson and Johnson COVID-19 vaccine blood clots 03:08
Video credit: ABC15 Arizona - Published on April 28, 2021